MYERS MICHAEL (Chief Executive Officer) purchased 404.9% of their position (37.89K shares) of QUOIN PHARMACEUTICALS, LTD. on the open market
Open‑market purchase worth $28.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 9/5/2024ACC: 0001104659-24-097254
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+37.89K
Net shares
Net buyer
$28.9K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
37.89K acquired
Non-Derivative Transactions4
Ordinary Shares
Direct
Shares
+800.00
Price / share
$0.62
Trade value
$495.20
% of position
8.5%
9/3/2024
9.36K→10.16K
Ordinary Shares
Direct
Shares
+5.32K
Price / share
$0.66
Trade value
$3.49K
% of position
52.4%
9/4/2024
10.16K→15.48K
Ordinary Shares
Direct
Shares
+8.20K
Price / share
$0.75
Trade value
$6.13K
% of position
53.0%
9/4/2024
15.48K→23.68K
Ordinary Shares
Direct
Shares
+23.57K
Price / share
$0.80
Trade value
$18.80K
% of position
99.5%
9/4/2024
23.68K→47.25K
Total
Net shares
+37.89K
Net value
$28.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/3/2024 | P · Purchase | +800.00 | $0.62 | $495.20 | 8.5% | 9.36K | 10.16K |
| Ordinary Shares Direct | 9/4/2024 | P · Purchase | +5.32K | $0.66 | $3.49K | 52.4% | 10.16K | 15.48K |
| Ordinary Shares Direct | 9/4/2024 | P · Purchase | +8.20K | $0.75 | $6.13K | 53.0% | 15.48K | 23.68K |
| Ordinary Shares Direct | 9/4/2024 | P · Purchase | +23.57K | $0.80 | $18.80K | 99.5% | 23.68K | 47.25K |
| Total | +37.89K | $28.92K | ||||||
Derivative Transactions0
No derivative transactions reported